The notices it replaced
- Reissues: PA-11-096 PHS 2011-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 2 steps back: PA-10-050 PHS 2010-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
- 3 steps back: PA-09-080 PHS 2009-02 Omnibus Solicitation of the NIH, CDC, FDA and ACF for Small Business Innovation Research Grant Applications (Parent SBIR [R43/R44])
Replaced by PA-13-088.
Who won it before
14 competing awards (new and renewals) from FY2014 to FY2025 under this notice and the notices it replaced: $4,307,909 in first-year total cost, median $237,649.
Most frequent study sections
- Special Emphasis Panel[ZRG1 IDM-U (10)]3
- Special Emphasis Panel[ZRG1 RPHB-C (10)]3
- Special Emphasis Panel[ZRG1 ETTN-G (12)]2
- Special Emphasis Panel[ZRG1 AARR-E (11)]1
- Special Emphasis Panel[ZRG1 ETTN-B (90)]1
Most frequent institutions
- ARISAN THERAPEUTICS, INC.1
- ASHWIN-USHAS CORPORATION, INC.1
- CARBONIX, LLC1
- ENTERTAINMENT SCIENCE PLAYMATICS, JV1
- L2 DIAGNOSTICS, LLC1
| FY | Project | PIs | Institution | First-year cost | Study section |
|---|---|---|---|---|---|
| 2014 | Allergens and Induced Asthma: Eradicating Indoor Allergens from Dust Mites (Phase2R44ES019790-02 | QUICK, ALLAN M. | CARBONIX, LLC, SC | $552,991 | ZRG1 |
| 2014 | Fast-Switching, High-Contrast, Electrochromic Sunwear for Persons with Age-Relate2R44AG039897-02 | CHANDRASEKHAR, PRASANNA | ASHWIN-USHAS CORPORATION, INC., NJ | $536,295 | ZRG1 |
| 2014 | Identification of novel broad-spectrum Dengue antivirals1R43AI104106-01 | HENKEL, GREGORY WILLIAM | ARISAN THERAPEUTICS, INC., CA | $449,400 | ZRG1 |
| 2014 | Electronic Alcohol Screening and Intervention in Work Settings1R44AA022570-01 | BENNETT, JOEL B | ORGANIZATIONAL WELLNESS & LEARNING SYS, TX | $448,478 | ZRG1 |
| 2014 | Therapeutic Development of RNAi-based inhibitors against the Hepatitis Delta Viru1R43AI104007-01A1 | JOHNSTON, BRIAN H. | SOMAGENICS, INC., CA | $389,582 | ZRG1 |
| 2014 | BREATHE FREE: Smartphone Videogame-Based Incentives for Smoking Cessation1R44DA036252-01 | RAIFF, BETHANY RRAPOZA, DARION | ENTERTAINMENT SCIENCE PLAYMATICS, JV, NC | $294,464 | ZRG1 |
| 2014 | Targeted Inactivation of the CCR5 HIV Coreceptor with Peptide Nucleic Acids1R43AI104355-01 | PETERSON-ROTH, ELIZABETH | L2 DIAGNOSTICS, LLC, CT | $250,298 | ZRG1 |
| 2014 | Fungal Metabolites as Novel Anthelmintics against Soil-Transmitted Helminthes.1R43AI100316-01A1 | PEARCE, CEDRIC JOHN | MYCOSYNTHETIX, INC., NC | $225,000 | ZRG1 |
| 2014 | Child Safety Seat with Harness Pretensioner1R43HD083878-01A1 | SEIFERT, SARA | MINNESOTA HEALTHSOLUTIONS CORPORATION, MN | $225,000 | ZRG1 |
| 2014 | Web-Based Training in Alcohol SBIRT for Youth Aged 9-181R43AA022571-01 | BIRNEY, AMELIA JMCPHERSON, TRACY L | OREGON CENTER FOR APPLIED SCIENCE, INC., AZ | $225,000 | ZRG1 |
| 2014 | Head-Steerable Device for Basic Vision Function1R43EY023483-01 | ARDITI, ARIES ROBERT | VISIBILITY METRICS, LLC, NY | $224,992 | ZRG1 |
| 2014 | Multi-modal AO-LSO Phase Gradient Imaging of the Inner Retina1R43EY023481-01 | FERGUSON, R DANIEL | PHYSICAL SCIENCES, INC, MA | $203,154 | ZRG1 |
| 2014 | Novel flavonoids as anti-inflammatory agents in alcoholism1R43AA021038-01 · under PA-11-096 | LITTLETON, JOHN M. | NAPROGENIX, INC, KY | $150,900 | ZRG1 |
| 2014 | A new device to improve screening of corneal transplant tissue1R43EY023117-01A1 | SARVER, EDWIN JAY | SARVER AND ASSOCIATES, INC., TN | $132,355 | ZRG1 |
Data: Grants.gov's daily extract and NIH's notice pages and award files, in ScienceGraph release conductgrants-2026-11-09-0.1.0. An award is listed only where NIH's own record names the notice, and a PI only by NIH's profile ID. Grants.gov and NIH do not endorse ScienceDex.